Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05419817
Title Pembrolizumab With Sitravatinib in Recurrent Endometrial Cancer and Other Solid Tumors With Deficient Mismatch Repair System
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Haider Mahdi

Advanced Solid Tumor

endometrial cancer


Pembrolizumab + Sitravatinib

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST